Naunyn-Schmiedebergs Archives of Pharmacology 1991-08-01

2-Nicotinamidoethyl acetate (SG-209) is a potassium channel opener: structure activity relationship among nicorandil derivatives.

T Ishibashi, M Hamaguchi, S Imai

Index: Naunyn Schmiedebergs Arch. Pharmacol. 344 , 235-239, (1991)

Full Text: HTML

Abstract

The mechanism of the vasodilating action of 2-nicotinamidoethyl acetate (SG-209), a derivative of nicorandil, was examined in the isolated rabbit aorta. Comparison was made using 2-nicotinamidoethyl alcohol (SG-86) and 2-nicotinamidoethyl nitrate (nicorandil; SG-75) to reveal any structure-activity relationships. SG-209 and nicorandil caused concentration-dependent relaxation in preparations precontracted with phenylephrine (10(-7) mol/l), while SG-86 produced a relaxation only at very high concentrations. The pD2 values (-log[EC50]) of SG-209 and nicorandil were 3.59 +/- 0.07 and 5.95 +/- 0.10, respectively. The vasorelaxant activity of nicorandil was associated with significant increases in cyclic GMP content, while that of SG-209 was not. Methylene blue (10(-5) mol/l) attenuated the relaxant effect of nicorandil, but had no effect on that of SG-209. Furthermore, the relaxant effect of nicorandil was not affected by glibenclamide (10(-5) mol/l), whilst the relaxant effect of SG-209 was abolished by this compound. In the presence of methylene blue (10(-5) mol/l), however, glibenclamide (10(-5) mol/l) attenuated the relaxant effect of higher concentrations of nicorandil (greater than or equal to 10(-5) mol/l). These results indicate that the relaxant effect of SG-209 is mostly if not exclusively due to the activation of potassium channels, while this action contributes to the vasodilating action of nicorandil only at higher concentrations.


Related Compounds

  • SG 209

Related Articles:

ATP-sensitive potassium channel activation induces angiogenesis in vitro and in vivo.

2015-07-01

[J. Pharmacol. Exp. Ther. 354 , 79-87, (2015)]

Nicorandil inhibits degranulation and TNF-alpha release from RBL-2H3 cells.

2002-04-01

[Inflamm. Res. 51 , 176-181, (2002)]

A further study of the vasodilator and negative inotropic mechanisms of action of nicorandil and its congeners in the canine heart.

1994-04-01

[Cardiovasc. Drugs Ther. 8 , 227-234, (1994)]

Effects of nicorandil and its congeners on musculature and vasculature of the dog trachea in situ.

1982-08-01

[Arch. Int. Pharmacodyn. Ther. 258(2) , 260-6, (1982)]

Nicorandil inhibits the release of TNFalpha from a lymphocyte cell line and peripheral blood lymphocytes.

2003-11-01

[Int. Immunopharmacol. 3(12) , 1581-8, (2003)]

More Articles...